← Leaderboards
Stephanie K Florio
Anagin
$6,567,391
Attributed
$6,567,391
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,567,391 · 3
By mechanism
U44$3,311,688 · 1
R44$2,888,016 · 1
R43$367,687 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainPatient SubsetsMediatingN-Methyl-D-Aspartate ReceptorsPainful NeuropathyPathologic ProcessesComplexMaintenanceNerve DegenerationN-MethylaspartateChronic Neuropathic PainGabapentinAffectHealthcare SystemsAmericanChronic PainAnalgesicsLeadAnalogIn VitroExhibitsNitric Oxide Synthase Type ICellsPeptides
Grant awards (8)
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics$814,748
U44 · FY2024 · NS · contact PI
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics$1,034,659
U44 · FY2023 · NS · contact PI
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics$962,495
U44 · FY2022 · NS · contact PI
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics$499,786
U44 · FY2021 · NS · contact PI
Development of novel small molecule analgesics modulating the nNOS-NOS1AP protein-protein interaction$286,072
R44 · FY2020 · NS · contact PI
Development of novel small molecule analgesics modulating the nNOS-NOS1AP protein-protein interaction$1,103,900
R44 · FY2019 · NS · contact PI
Development of novel small molecule analgesics modulating the nNOS-NOS1AP protein-protein interaction$1,498,044
R44 · FY2018 · NS · contact PI
High throughput screen to identify small molecule analgesics targeting nNOS-NOS1AP protein-protein interactions$367,687
R43 · FY2016 · NS · contact PI